Schubert & CO Seagen Inc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$117.37 - $139.17 $1,643 - $1,948	-14 Reduced 53.85%	12 $1,000
Q3 2022 Oct 21, 2022	BUY	$135.27 - $180.11 $676 - $900	5 Added 23.81%	26 $4,000
Q2 2022 Aug 01, 2022	BUY	$108.81 - $179.33 $1,305 - $2,151	12 Added 133.33%	21 $4,000
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $119 - $157	1 Added 12.5%	9 $1,000
Q4 2021 Jan 28, 2022	BUY	$142.57 - $190.86 $1,140 - $1,526	8 New	8 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.